These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 825711)

  • 1. [Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
    Tilz GP; Teubl I; Kopplhuber C; Vollmann H; Lanzer G
    Med Klin; 1976 Nov; 71(45):1952-7. PubMed ID: 825711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical use of plasmapheresis].
    Del Favero A; Morelli A; Narducci F
    Clin Ter; 1981 Jan; 96(1):93-9. PubMed ID: 6786819
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
    Di Lollo F; Fazzini G; Avanzi G
    Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasmapheresis].
    Speiser P
    Wien Klin Wochenschr; 1967 Sep; 79(38):689-92. PubMed ID: 4969820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic separation of blood components in clinical emergency medicine].
    Lanzer G; Tilz GP
    Wien Med Wochenschr; 1986 Mar; 136(5-6):134-7. PubMed ID: 2941922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
    Ryzhko VV; Gorodetskiĭ VM
    Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmapheresis and cold sensitivity of immunoglobulin molecules. II. A study of macroglobulinemia polyclonalis spuria and immune complex disease.
    Waldenström JG
    Acta Med Scand; 1984; 216(5):467-74. PubMed ID: 6240922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with limited plasma exchange as a mode of therapy in some immunological diseases.
    Malaviya AN; Nanu A; Taneja N; Raina V; Pati A; Garg R; Rana DS; Narayanan K
    J Assoc Physicians India; 1982 Dec; 30(12):899-901. PubMed ID: 6223917
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperviscosity syndrome (author's transl)].
    Yoshinaga K; Onodera K
    Kokyu To Junkan; 1978 Nov; 26(11):1059-63. PubMed ID: 103156
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+ T lymphocytes and interleukin 2 in myelomatous blood hyperviscosity syndrome treated with plasmapheresis.
    Usnarska-Zubkiewicz L
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):317-22. PubMed ID: 9832072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 19. [Discontinuous plasma exchange with the conventional hemodialysis technic and blood cell centrifugation].
    Achenbach H; Haustein B; Baumann I; Raabe F; Meissner S; Kubel M
    Z Urol Nephrol; 1983 Jul; 76(7):465-72. PubMed ID: 6227162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma exchange therapy (plasmapheresis/plasmafiltration). II. Indications and complications].
    Quietzsch D; Liebert A; Zimmermann S
    Z Gesamte Inn Med; 1984 Oct; 39(20):493-500. PubMed ID: 6549091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.